The role of matrix metalloproteinases in the pathogenesis of endometriosis(literature review)

Close metadata

Recommended articles:

Immunological aspects of endometriosis: pathophysiological mechanisms, diagnosis, autoimmunity, targeted therapy and modulation. Russian Journal of Human Reproduction. 2024;(2):15-31

Analysis of the effectiveness of various methods of managing patients with endometriosis and justification for long-term personalized anti-relapse therapy with dydrogesterone as part of their combination treatment strategy. Russian Journal of Human Reproduction. 2024;(2):102-111

Infiltrating Endometriosis of the Distal Part of Round Uterine Ligament and It’s Association with Nuck’s Diverticulum (Literature Review and Case Report). Russian Journal of Human Reproduction. 2024;(2):112-121

Clinical and morphological assessment of patients with adenomyosis: own data. Russian Journal of Human Reproduction. 2024;(2):130-135

Endometriosis and genital malformations in children and adolescents. What do they have in common?. Russian Journal of Human Reproduction. 2024;(3):14-22

Genetic factors in degenerative disc disease. Burdenko's Journal of Neurosurgery. 2024;(2):112-118

Pathogenetic, clinical-diagnostic and therapeutic aspects of premenstrual syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):37-42

Morphological features of vasoproliferative tumor of the retina. Russian Journal of Archive of Pathology. 2024;(2):42-50

Cognitive impairment in multiple system atrophy — exclusion criteria or an integral part of the clinical picture?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):86-91

B vitamins and diseases of the peripheral nervous system. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):75-82

Data on matrix metalloproteinases, their classification depending on substrate specificity, tissue inhibitors, and their role in the pathogenesis of endometriosis are presented.

Keywords:

endometriosis

adenomyosis

matrix metalloproteinases

pathogenesis

Authors:

Adamyan L.V.

Department of Reproductive Medicine and Surgery, Faculty of Postgraduate Professional Education, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia

SPIN RSCI: 9836-2713
Scopus AuthorID: 7006372422
ResearcherID: Q-1722-2018
ORCID: 0000-0002-3253-4512

Manukyan L.M.

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia

Loginova O.N.

Kafedra reproduktivnoĭ meditsiny i khirurgii fakul'teta poslediplomnogo obrazovaniia Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Arslanyan K.N.

Zayratyants V.O.

A.I. Evdokimov Moscow State Medical Stomatological University, Moscow, Russia

List of references:

Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostor AG, Nie G, Lopata A, Salamonsen LA. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. 2002;94:1466-1475.
Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, Hitomi K, Kitaura Y, Takai S, Sasahara RM, Horimoto A, Ikawa Y, Ratzkin BJ, Arakawa T, Noda M. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. 1998;95(22):13221-13226.
Verma RP, Hansch C. Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs. 2007;15:2223-2268.
Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC, Gorstein F. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. 1993;168(1 Pt 1):253-260.
Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F, Osteen KG. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. 1994;94(3):946-953.
Chevronnay Gaide HP, Selvais C, Emonard H, Galant C, Marbaix E, Henriet P. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. 2012;1824(1):146-156.
Amălinei C, Căruntu ID, Giuşcă SE, Bălan RA. Matrix metalloproteinases involvement in pathologic conditions. 2010;51(2):215-228.
The Comprehensive Enzyme Information System. Classification and Substrate Specificity of Matrix Metalloproteinases. Accessed February 09, 2020. Available at:
Ayuk SM, Abrahamse H, Houreld NN. The role of matrix metalloproteinases in diabetic wound healing in relation to photobiomodulation. 2016;2897656.
Chung L, Dinakarpandian D, Yoshida N, Lauer-Fields JL, Fields GB, Visse R, Nagase H. Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. 2004; 23(15):3020-3030.
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. 2003;92(8):827-839.
Herman MP, Sukhova GK, Kisiel W, Foster D, Kehry MR, Libby P, Schonbeck U. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. 2001;107(9):1117-1126.
Tardif G, Reboul P, Pelletier JP, Martel-Pelletier J. Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3). 2004;14(3):197-204.
Patterson ML, Atkinson SJ, Knauper V, Mupphy G. Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. 2001;503(2-3):158-162.
Hashizume K. Analysis of utero-placental-specific molecules and their functions during implantation and placentacion in the bovine. 2007;53(1):1-11.
Osteen G, Igarashi TM, Bruner-Tran KL. Progesterone action in the human endometrium: induction of a unique tissue environment which limits matrixmetalloproteinase (MMP) expression. 2003;7:78-86.
Ii M, Yamamoto H, Adachi Y, Maroyama Y, Shinomura Y. Role of MMP-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. 2006;231(1): 20-27.
Nemori R, Yamamoto M, Kataoka F, Hashimoto G, Arakatsu H, Shiomi T, Okada Y. Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1). 2005;53(10):1227-1234.
Burke B. The role of matrix metalloproteinase 7 in innate immunity. 2004;209(1-2):51-56.
Harrell PC, Mccawley LJ, Fingleto B, Mcintire JO, Matrisian LM. Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. 2005;303(2):308-320.
Ahokas K, Skoog T, Suomela S, Jeskanen L, Impola U, Isaka K, Saarialgho-Kere U. Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis. 2005;124(4):849-856.
Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. 2003;22(2-3):145-152.
Zucker S, Pei D, Cao J, Lopez-Otin C. Membrane typematrix metalloproteinases (MT-MMP). 2003;54:1-74.
Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. 2002;3(10):753-766.
Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. 2004;48(5-6):411-424.
Pepper MS. Extracellular proteolysis and angiogenesis. 2001;86(1):346-355.
English WR, Puente XS, Freije JM, Knauper V, Amour A, Marryweather A, Lopez-Otin C, Murphy G. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate Pro-MMP2. 2000;275(19):14046-14055.
Pei D. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. 1999;9(4):291-303.
Kang T, Yi J, Guo A, Wang X, Overall CM, Jiang W, Elde R, Borrecaard N, Pei D. Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6MMP/MMP25 in neutrophils. 2001;276(24):21960-21968.
Velasco G, Cal S, Merlos-Suarez A, Ferrando AA, Alvares S, Nakano A, Arribas J, Lopez-Otin C. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. 2000;60(4):877-882.
Nie J, Pei D. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond. 2003;63(20):6758-6762.
Gezer A, Oral E. Progestin therapy in endometriosis. 2015;11:643-652.
Mönckedieck V, Sannecke C, Husen B, Kumbartski M, Kimmig R, Tötsch M, Winterhager E, Grümmer R. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model. 2009;15:633-643.
Sillem M, Prifti S, Neher M, Runnebaum B. Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis. 1998; 4:730-735.
Shan B, Li W, Yang SY, Li ZR. Estrogen up-regulates MMP2/9 expression in endometrial epithelial cell via VEGF-ERK1/2 pathway. 2013;6:826-830.
Huang HF, Hong LH, Tan Y, Sheng JZ. Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. 2004;81:1235-1239.
Parkin KL, Fazleabas AT. Uterine leukocyte function and dysfunction: A hypothesis on the impact of endometriosis. 2016;75:411-417.
Braundmeier AG, Nowak RA. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. 2006;56(3):201-214.
Chegini N. TGF-beta system: the principal profibrotic mediator of peritoneal adhesion formation. 2008;26(4):298-312.
Singer CF, Marbaix E, Lemoine P, Courtoy PJ, Eeckhout Y. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. 1999;259(1-2):40-45.
Mulayim N, Savlu A, Guzeloglu-Kayisli O, Kayisli UA, Arici A. Regulation of endometrial stromal cell matrix metalloproteinase activity and invasiveness by interleukin-8. 2004; 81(suppl 1):904-911.
Singer CF, Marbaix E, Kokorine I, Lemoine P, Donnez J, Eeckhout Y, Courtoy PJ. Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1alpha and its dual block by ovarian steroids. 1997;94(19):10341-10345.
Khoufache K, Bondza PK, Harir N, Daris M, Leboeuf M, Mailloux J, Lemyre M, Foster W, Akoum A. Soluble human IL-1 receptor type 2 inhibits ectopic endometrial tissue implantation and growth: identification of a novel potential target for endometriosis treatment. 2012;181(4):1197-1205.
Quattrone F, Sanchez AM, Pannese M, Hemmerle T, Viganò P, Candiani M, Petraglia F, Neri D, Panina-Bordignon P. The Targeted Delivery of Interleukin 4 Inhibits Development of Endometriotic Lesions in a Mouse Model. 2015;22(9): 1143-1152.
Kumar R, Clerc AC, Gori I, Russell R, Pellegrini C, Govender L, Wyss JC, Golshayan D, Canny GO. Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling. 2014;9(2):89742.
Lee J, Banu SK, Subbarao T, Starzinski-Powitz A, Arosh JA. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases. 2011;332(1-2):306-313.
Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. 1987;6(7):1899-1904.
Ulukus M, Cakmak H, Arici A. The role of endometrium in endometriosis. 2006; 13:467-476.
Collette T, Maheux R, Mailloux J, Akoum A. Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis. 2006;21:3059-3067.
Sotnikova NY, Antsiferova YS, Posiseeva LV, Shishkov DN, Posiseev DV, Filippova ES. Mechanisms regulating invasiveness and growth of endometriosis lesions in rat experimental model and in humans. 2010;93(8):2701-2705.
Lu XE, Ning WX, Dong MY, Liu AX, Jin F, Huang HF. Vascular endothelial growth factor and matrix metalloproteinase-2 expedite formation of endometriosis in the early stage ICR mouse model. 2006;86(4):1175-1181.
Ueda M, Yamashita Y, Takehara M, Terai Y, Kumagai K, Ueki K, Kanda K, Hung YC, Ueki M. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis. 2002;16(5):391-402.
Uzan C, Cortez A, Dufournet C, Fauvet R, Siffroi JP, Daraï E. Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2. 2004;445(6): 603-609.
Kokorine I, Nisolle M, Donnez J, Eeckhout Y, Courtoy PJ, Marbaix E. Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. 1997;68(2):246-251. ) 81510-5
Cominelli A, Gaide Chevronnay HP, Lemoine P, Courtoy PJ, Marbaix E, Henriet P. Matrix metalloproteinase-27 is expressed in CD163+/CD206+ M2 macrophages in the cycling human endometrium and in superficial endometriotic lesions. 2014;20(8):767-775.
Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. 1997;99(12):2851-2857.

Close metadata